Group | ALV/placebo Inoculation | Vaccination | BLP/placebo Inoculation |
---|---|---|---|
Mock Control | DMEM | NDV + AIV | purified BL21 culture |
Mock BLP | DMEM | NDV + AIV | 50 μg purified BLP |
Infection Control | 2.0 × 105 TCID50 | NDV + AIV | purified BL21 culture |
Infection BLP | 2.0 × 105 TCID50 | NDV + AIV | 50 μg purified BLP |